+343.0%
MRNA vs AVAV
-29.4%
+372.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | AVAV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -2.7% | -0.7% | -2.8% |
| 7D | -12.1% | +4.2% | -16.3% | -12.8% |
| 30D | -1.3% | -2.6% | +1.3% | -1.2% |
| 3M | +250.9% | -38.0% | +288.9% | +292.0% |
| 6M | +343.0% | -27.0% | +370.0% | +375.8% |
| All | +343.0% | -29.4% | +372.4% | +375.8% |
Cumulative growth
Daily Returns
Daily percentage return beside AVAV.
Daily Out/Under-Performance
Portfolio return minus AVAV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded AVAV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling